[1]
“Screening the adequacy of hydroxychloroquine prescription and monitoring of ocular toxicity in patients with rheumatic disease”, J Fatima Jinnah Med Univ, vol. 14, no. 03, pp. 128–131, Dec. 2020, doi: 10.37018/zbsl5515.